Smokers inhale more tar, nicotine and carbon monoxide when measured with WHO method RIVM has measured the amount of tar, nicotine and carbon monoxide (TNCO) in all filter cigarettes sold in the Netherlands with the WHO Intense method.
New study confirms: people in the Netherlands ingest too much PFAS People in the Netherlands are ingesting too much levels of PFAS through food and drinking water. New research by RIVM confirms this. However, the total quantity of PFAS is lower than previously calculated.
No major change in air quality in the Netherlands in 2022 The overall air quality in 2022 was slightly worse than in 2021. Weather conditions such as temperature and drought played an important role in this difference. This is according to the large-scale concentration maps published by RIVM each year.
Launch of Integrated Health Monitor COVID-19: large-scale study on public health impact of COVID-19 RIVM, the collective Municipal Public Health Services (GGDs) in collaboration with GGD GHOR, the NIVEL Netherlands Institute for Health Services Research and ARQ National Psychotrauma Centre have developed a new monitor: the Integrated Health Monitor
Vaccination coverage increases for second consecutive year, by 10% for HPV The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.
Insight into hospital admissions for acute respiratory infections In order to achieve an accurate overview of how often respiratory infections occur in the Netherlands, it is important to know how many patients are admitted to hospital with a respiratory infection.
People who had one jab after having COVID-19 now included in vaccination coverage figures for full vaccination Vaccination coverage in the Netherlands rose more sharply this week than in previous weeks, increasing to 81.7% among people aged 18 years and older and 79.0% among those aged 12 years and older.
Vaccination figures now available by municipality RIVM is providing access to COVID-19 vaccination figures by municipality via open data as of today. The open data now includes vaccination turnout and coverage by municipality for three age groups.
New international project Inno4Vac targets faster vaccine development Inno4vac, a new European interdisciplinary project was launched on 1 September. Inno4vac focuses on the design and application of new and highly advanced predictive models to allow a faster development and manufacturing of new vaccines.